BlackRock Inc. Has $223.97 Million Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

BlackRock Inc. decreased its stake in Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 2.9% in the third quarter, HoldingsChannel reports. The firm owned 13,565,624 shares of the company’s stock after selling 406,434 shares during the period. BlackRock Inc. owned 0.16% of Pediatrix Medical Group worth $223,971,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Eagle Bay Advisors LLC boosted its holdings in shares of Pediatrix Medical Group by 122.5% in the second quarter. Eagle Bay Advisors LLC now owns 1,595 shares of the company’s stock worth $34,000 after buying an additional 878 shares during the period. Bank of America Corp DE boosted its stake in Pediatrix Medical Group by 0.3% in the 1st quarter. Bank of America Corp DE now owns 278,204 shares of the company’s stock worth $6,532,000 after purchasing an additional 933 shares during the period. Cubist Systematic Strategies LLC grew its position in Pediatrix Medical Group by 3.9% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 26,562 shares of the company’s stock worth $439,000 after purchasing an additional 1,008 shares in the last quarter. MetLife Investment Management LLC raised its stake in Pediatrix Medical Group by 2.4% during the 3rd quarter. MetLife Investment Management LLC now owns 45,151 shares of the company’s stock valued at $745,000 after purchasing an additional 1,040 shares during the period. Finally, Royal Bank of Canada lifted its holdings in shares of Pediatrix Medical Group by 97.3% in the third quarter. Royal Bank of Canada now owns 2,166 shares of the company’s stock valued at $35,000 after purchasing an additional 1,068 shares in the last quarter. Hedge funds and other institutional investors own 95.99% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on MD shares. Mizuho dropped their price target on Pediatrix Medical Group from $21.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 16th. Credit Suisse Group dropped their target price on Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating on the stock in a report on Wednesday, February 22nd. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $19.00.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD opened at $14.28 on Tuesday. Pediatrix Medical Group, Inc. has a one year low of $14.15 and a one year high of $24.67. The business’s 50-day moving average price is $15.42 and its two-hundred day moving average price is $16.23. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.00 and a quick ratio of 1.00. The company has a market capitalization of $1.19 billion, a P/E ratio of 17.85, a price-to-earnings-growth ratio of 2.20 and a beta of 1.75.

About Pediatrix Medical Group

(Get Rating)

Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.